WST
West Pharmaceutical Services Inc
375.90$
+1.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.1% | -5.0% | +1.0% | +6.4% | +0.2% | -6.7% | +9.7% | +5.0% | +0.1% | +5.0% | +3.2% | – | |
| – | -1.1% | +2.4% | +1.4% | +2.3% | -1.6% | -1.8% | +5.9% | +3.6% | -1.9% | +9.5% | -1.0% | – | |
| – | -3.6% | -17.1% | +0.0% | +14.7% | +3.5% | -15.2% | +17.4% | +7.4% | +3.5% | -2.5% | +11.1% | – | |
| – | +12.2% | -4.3% | -0.6% | -11.4% | +19.4% | -11.9% | +17.2% | -10.5% | +27.5% | -27.5% | +24.7% | – | |
| – | +1.1% | -3.7% | -4.3% | +0.6% | +2.2% | +3.2% | +9.0% | +7.1% | +3.7% | -6.6% | +18.2% | – | |
| – | +10.2% | -3.8% | -3.6% | -3.1% | +6.6% | +0.5% | +10.3% | +4.2% | +22.5% | -18.7% | +25.8% | – | |
| – | -10.7% | -25.6% | +3.0% | +28.3% | +1.7% | -24.7% | +23.2% | +9.8% | -9.8% | +13.1% | +1.1% | – | |
| – | -62.1% | +36.4% | +0.0% | -53.3% | +14.3% | -50.0% | -75.0% | +0.0% | +5,200.0% | -64.2% | +36.8% | – | |
| – | -10.1% | -23.2% | +1.1% | +26.4% | -0.9% | -31.8% | +42.2% | +7.4% | -4.9% | +8.9% | +0.0% | – | |
| – | +17.3% | -52.5% | +33.5% | +47.9% | +13.6% | -34.5% | +25.3% | +12.6% | -2.1% | +34.2% | -28.0% | – | |
| – | -15.1% | -15.8% | -3.5% | +22.2% | -4.3% | -31.0% | +46.8% | +6.2% | -5.6% | +5.1% | +11.0% | – | |
| – | -9.0% | -19.8% | +2.8% | +21.5% | +0.1% | -26.6% | +31.5% | +9.4% | -3.5% | +4.3% | -18.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.